Home / Ivabradine / United States
US ATC C01EB17 · updated 2 Nov 2026
Ivabradine shortage in United States
Is there an Ivabradine shortage in United States?
Yes. As of 2 Nov 2026, 3 Ivabradine products are reported short in United States, the first since 24 Mar 2026. No return date has been given. Main reason: not stated.
Also short in Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28) discontinuation | Amgen Inc. | 24 Mar 2026 | not given | Not stated |
| US | Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60) discontinuation | Amgen Inc. | 24 Mar 2026 | not given | Not stated |
| US | Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60) discontinuation | Amgen Inc. | 24 Mar 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).